(secondQuint)Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT).

 The study was performed as a randomized, multicentre, double-blind, placebo- controlled, parallel-group, phase III trial with BF-200 ALA and placebo in seven centres in Germany.

 A total of 94 patients were screened in this study; 87 were randomized (55 patients received BF-200 ALA, 32 received placebo).

 Patients received one PDT.

 If residual lesions remained at 3 months after treatment, PDT was repeated.

 Illumination was performed with the PDT lamp BF-RhodoLED.

.

 Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)@highlight

The purpose of this study is to evaluate the safety and efficacy of BF-200 ALA (Ameluz) versus placebo in the field-directed treatment of mild to moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED lamp.

